HomeInsightsPB

Alembic Pharmaceuticals Ltd PB Ratio

Alembic Pharmaceuticals Ltd PB Ratio

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

1.4 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

PB

4.3

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Alembic Pharmaceuticals Ltd is 4.3 as of 07 Nov 24.
  • The P/B Ratio of Alembic Pharmaceuticals Ltd changed from 2.8 on March 2022 to 4 on March 2024 . This represents a CAGR of 12.62% over 3 years. .

Historical P/B Ratio of Alembic Pharmaceuticals Ltd

No data available

Company Fundamentals for Alembic Pharmaceuticals Ltd

Market Cap

21,257 Cr

EPS

32.4

P/E Ratio (TTM) *

33.4

P/B Ratio (TTM) *

4.3

Day’s High *

1093.45

Day’s Low

1070.3

DTE *

0.2

ROE *

13.2

52 Week High

1296.15

52 Week Low

710.5

ROCE *

12.8

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241081.45
06 Nov 20241139.2
05 Nov 20241126.3
04 Nov 20241124.65
01 Nov 20241121.4
31 Oct 20241128.75
30 Oct 20241083.3
29 Oct 20241061.6
28 Oct 20241074.2
25 Oct 20241068.5

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Alembic Pharmaceuticals Ltd421,257
Sun Pharmaceuticals Industries Ltd994,29,841
Divis Laboratories Ltd5161,58,179
Cipla Ltd3621,27,063
Mankind Pharma Ltd2651,09,234
Dr Reddys Laboratories Ltd3191,07,398

Key Valuation Metric of Alembic Pharmaceuticals Ltd

Share Price

₹1,077

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma gets USFDA nod for hypertension treatment drug

The said drug is therapeutically equivalent to the reference listed drug product (RLD), Di...

Read more

21 Oct 202411:23

News

Alembic Pharmaceuticals to discuss results

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 ...

Read more

18 Oct 202417:20

News

Alembic Pharma's oncology formulations unit successfully completes USFDA inspection

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Adminis...

Read more

09 Oct 202409:16

News

Alembic Pharma rises after oncology facility completes US FDA audit with 'zero' observations

The US FDA had conducted an inspection at the company's oncology (injectable and oral soli...

Read more

09 Oct 202409:21

News

Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

04 Oct 202409:29

News

Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...

Read more

03 Oct 202409:23

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

FAQs for PB Ratio of Alembic Pharmaceuticals Ltd

What is the PB ratio of Alembic Pharmaceuticals Ltd?

The current PB ratio of Alembic Pharmaceuticals Ltd is 4.35. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Alembic Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Alembic Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Alembic Pharmaceuticals Ltd calculated?

The PB ratio of Alembic Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Alembic Pharmaceuticals Ltd?

A high PB ratio suggests that Alembic Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Alembic Pharmaceuticals Ltd?

A low PB ratio of Alembic Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Alembic Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Alembic Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*